• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

γ珠蛋白基因5'端的-158位点与γ珠蛋白表达。

The -158 site 5' to the G gamma gene and G gamma expression.

作者信息

Labie D, Dunda-Belkhodja O, Rouabhi F, Pagnier J, Ragusa A, Nagel R L

出版信息

Blood. 1985 Dec;66(6):1463-5.

PMID:4063531
Abstract

To test the hypothesis advanced by Gilman and Huisman that the -158 site 5' to the G gamma gene determines the G gamma expression after the first 4 months of life, we have examined DNA from sickle cell anemia (SS) patients from Africa and beta-thalassemic homozygotes from Algeria. We find that the Xmnl site is strongly linked to the Senegal haplotype among SS patients, to haplotype IX (most probably identical to the Senegal haplotype), and to haplotype III among the Algerian thalassemics. Thalassemics with haplotypes I/I and V/V have no Xmnl site and low G gamma expression. In contrast, beta-thalassemia-associated haplotype II (also characterized by high G gamma expression) fails to exhibit the Xmnl site. We conclude that, although highly correlated, the -158 C----T substitution does not perfectly predict the presence of high G gamma expression. These findings also exclude the possibility that the Xmnl site is solely involved in the determination of high G gamma expression and suggest that either several different site substitutions in the area 5' to the gamma gene might have the same effect or that, alternatively, the Xmnl site and its surrounding area is not involved in G gamma expression and may be only in linkage disequilibrium with a controlling sequence elsewhere.

摘要

为了验证吉尔曼和休斯曼提出的假说,即位于Gγ基因5'端-158位点决定出生后前4个月后的Gγ表达,我们检测了来自非洲的镰状细胞贫血(SS)患者以及来自阿尔及利亚的β地中海贫血纯合子的DNA。我们发现,在SS患者中,XmnI位点与塞内加尔单倍型紧密连锁,在阿尔及利亚地中海贫血患者中,与单倍型IX(很可能与塞内加尔单倍型相同)以及单倍型III紧密连锁。具有单倍型I/I和V/V的地中海贫血患者没有XmnI位点且Gγ表达较低。相反,与β地中海贫血相关的单倍型II(也以高Gγ表达为特征)没有XmnI位点。我们得出结论,尽管-158 C→T替换与高Gγ表达高度相关,但并不能完美预测高Gγ表达的存在。这些发现也排除了XmnI位点单独参与决定高Gγ表达的可能性,并表明要么γ基因5'端区域的几种不同位点替换可能具有相同的效应,要么XmnI位点及其周围区域不参与Gγ表达,可能仅与其他地方的一个控制序列处于连锁不平衡状态。

相似文献

1
The -158 site 5' to the G gamma gene and G gamma expression.γ珠蛋白基因5'端的-158位点与γ珠蛋白表达。
Blood. 1985 Dec;66(6):1463-5.
2
Common haplotype dependency of high G gamma-globin gene expression and high Hb F levels in beta-thalassemia and sickle cell anemia patients.β地中海贫血和镰状细胞贫血患者中高Gγ-珠蛋白基因表达与高Hb F水平的常见单倍型依赖性
Proc Natl Acad Sci U S A. 1985 Apr;82(7):2111-4. doi: 10.1073/pnas.82.7.2111.
3
Effect of beta-globin gene cluster haplotype on the hematological and clinical features of sickle cell anemia.β-珠蛋白基因簇单倍型对镰状细胞贫血血液学及临床特征的影响
Am J Hematol. 1991 Mar;36(3):184-9. doi: 10.1002/ajh.2830360305.
4
Beta-cluster haplotypes, alpha-gene status, and hematological data from SS, SC, and S-beta-thalassemia patients in southern California.南加州镰状细胞贫血(SS)、镰状细胞-血红蛋白C病(SC)和镰状细胞-β地中海贫血患者的β簇单倍型、α基因状态及血液学数据。
Hemoglobin. 1989;13(4):325-53. doi: 10.3109/03630268909003397.
5
The hematologic characteristics of sickle cell anemia bearing the Bantu haplotype: the relationship between G gamma and HbF level.携带班图单倍型的镰状细胞贫血的血液学特征:Gγ与HbF水平之间的关系。
Blood. 1987 Apr;69(4):1026-30.
6
Beta s-gene-cluster haplotypes in sickle cell anemia. Clinical and hematologic features.镰状细胞贫血中的β s基因簇单倍型。临床和血液学特征。
Hematol Oncol Clin North Am. 1991 Jun;5(3):475-93.
7
Genetic factors involved in human G gamma and A gamma globin gene expression.
Eur J Haematol. 1988 Apr;40(4):350-4. doi: 10.1111/j.1600-0609.1988.tb00190.x.
8
Beta S haplotypes in various world populations.世界各地人群中的β-S单倍型。
Hum Genet. 1992 Apr;89(1):99-104. doi: 10.1007/BF00207052.
9
The Xmn I site (-158, C----T) 5' to the G gamma gene: correlation with the Senegalese haplotype and G gamma globin expression.位于γ珠蛋白基因5'端的Xmn I位点(-158,C→T):与塞内加尔单倍型及γ珠蛋白表达的相关性。
Hemoglobin. 1991;15(5):393-405. doi: 10.3109/03630269108998859.
10
Beta S-gene-cluster haplotypes in sickle cell anemia: clinical implications.镰状细胞贫血中的β-S基因簇单倍型:临床意义
Am J Pediatr Hematol Oncol. 1990 Fall;12(3):367-74. doi: 10.1097/00043426-199023000-00022.

引用本文的文献

1
The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria.尼日利亚镰状细胞病中胎儿血红蛋白持续存在的遗传剖析。
Hum Mol Genet. 2024 May 4;33(10):919-929. doi: 10.1093/hmg/ddae014.
2
Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea.遗传修饰因子影响胎儿血红蛋白对羟基脲治疗镰状细胞病患者病程的影响。
Haematologica. 2022 Jul 1;107(7):1577-1588. doi: 10.3324/haematol.2021.278952.
3
Editing a γ-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype.
编辑 γ-珠蛋白抑制因子结合位点可恢复胎儿血红蛋白合成并纠正镰状细胞病表型。
Sci Adv. 2020 Feb 12;6(7). doi: 10.1126/sciadv.aay9392. Print 2020 Feb.
4
Omics Studies in Hemoglobinopathies.血红蛋白病的组学研究。
Mol Diagn Ther. 2019 Apr;23(2):223-234. doi: 10.1007/s40291-019-00386-1.
5
Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease.镰状细胞病中胎儿血红蛋白的遗传修饰物。
Mol Diagn Ther. 2019 Apr;23(2):235-244. doi: 10.1007/s40291-018-0370-8.
6
: a genetic model of fetal hemoglobin in sickle cell disease.镰状细胞病中胎儿血红蛋白的遗传模型。
Blood Adv. 2018 Feb 13;2(3):235-239. doi: 10.1182/bloodadvances.2017009811.
7
Concise Review: Epigenetic Regulation of Hematopoiesis: Biological Insights and Therapeutic Applications.简明综述:造血的表观遗传调控:生物学见解与治疗应用。
Stem Cells Transl Med. 2017 Dec;6(12):2106-2114. doi: 10.1002/sctm.17-0192. Epub 2017 Oct 28.
8
Existence of HbF Enhancer Haplotypes at Intergenic Region in Transfusion-Dependent Saudi -Thalassemia Patients.输血依赖型沙特β地中海贫血患者基因间区域HbF增强子单倍型的存在情况。
Biomed Res Int. 2017;2017:1972429. doi: 10.1155/2017/1972429. Epub 2017 Feb 9.
9
Study on Hydroxyurea Response in Hemoglobinopathies Patients Using Genetic Markers and Liquid Erythroid Cultures.利用遗传标记和液体红细胞培养研究血红蛋白病患者对羟基脲的反应
Hematol Rep. 2016 Dec 9;8(4):6678. doi: 10.4081/hr.2016.6678. eCollection 2016 Nov 2.
10
Genomic approaches to identifying targets for treating β hemoglobinopathies.用于鉴定β-血红蛋白病治疗靶点的基因组学方法。
BMC Med Genomics. 2015 Jul 29;8:44. doi: 10.1186/s12920-015-0120-2.